Supplier

REIMEKS PHARMA OOD

РЕИМЕКС ФАРМА ООД

Value won

BGN 6.8m+ €62.9k

Across 8 contracts won

A Bulgaria supplier, with 8 awarded contracts, most recently 6 months ago.

Bulgaria(inferred)

Value won

BGN 6.8m+ €62.9k

Across 8 contracts won

Contract history

8 entries

Most recent
1 Mar 2026
6 months ago
Biggest
BGN 6.3m
Supply of Odevixibat Pharmaceutical…
Average size
BGN 969.5k
Across 7 priced
Last 12 months
2
entries

Won · 8

Pharmaceutical Products Supply Contract€62,927 · 1 Mar 2026 Pharmaceutical Products SupplyBGN 108,919 · 25 Aug 2025 Supply of Pharmaceutical Products: ElectrolytesBGN 23,400 · 16 Jul 2025 Supply of Odevixibat Pharmaceutical ProductBGN 6,295,422 · 16 Jul 2025 Supply of Pharmaceutical ProductsBGN 51,667 · 10 Jul 2025 Pharmaceutical Products SupplyBGN 198,893 · 1 Jun 2025 Supply of Pharmaceutical ProductsBGN 102,996 · 11 May 2025 Pharmaceutical Products SupplyBGN 5,271 · 28 Apr 2025

Apr 25Jul 25Sept 25Dec 25Mar 26

Opportunities

Showing awarded · 8

AwardedHealthcare & MedicalBulgaria

Pharmaceutical Products Supply Contract

This contract is for the supply of pharmaceutical products, specifically Fenfluramine, an oral solution at a concentration of 2.2mg/ml in 120ml bottles. The awarded supplier, Reimex Pharma Ltd., is required to deliver 9 packages of this product as per the request from the University Multi-Profiling

€62,927UNIVERSITY MULTIDISCIPLINARY HOSPITAL FOR ACTIVE TREATMENT "ST. IVAN RILSKI" EAD

Published 1 Mar 2026

AwardedHealthcare & MedicalBulgaria

Pharmaceutical Products Supply

This contract involves the supply of pharmaceutical products, specifically the drug Odevixibat, which is listed under Article 266a, paragraph 2 of the Law on Medicinal Products for Human Use in Bulgaria. The buyer is the University Multi-Profile Hospital for Active Treatment 'St. George' EAD. Suppli

BGN 108,919UNIVERSITY MULTIPROFESSIONAL HOSPITAL FOR ACTIVE TREATMENT "SAINT GEORGE" EAD

Published 25 Aug 2025

AwardedHealthcare & MedicalBulgaria

Supply of Pharmaceutical Products: Electrolytes

This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) 'Electrolytes', which includes various salts in combination. The product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products in Human Medicine. The total va

BGN 23,400Specialized Hospital for Active Treatment of Pediatric Diseases - Prof. Ivan Mitev EAD

Published 16 Jul 2025

AwardedHealthcare & MedicalBulgaria

Supply of Odevixibat Pharmaceutical Product

This contract involves the supply of the pharmaceutical product Odevixibat, with an active ingredient of 1200 micrograms. The product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The buyer is the Specialized Hospital for Active Treatment of Children's Disease

BGN 6,295,422Specialized Hospital for Active Treatment of Pediatric Diseases - Prof. Ivan Mitev EAD

Published 16 Jul 2025

AwardedHealthcare & MedicalBulgaria

Supply of Pharmaceutical Products

This contract involves the delivery of the pharmaceutical product Koselugo, 10 mg, manufactured by AstraZeneca. The supplier is required to provide four packages, each containing sixty capsules. The total value of the contract is approximately €51,667. This opportunity is part of the health sector a

BGN 51,667University Multiprofile Hospital for Active Treatment "Tsaritsa Joanna-ISUL" EAD

Published 10 Jul 2025

AwardedHealthcare & MedicalBulgaria

Pharmaceutical Products Supply

This contract involves the supply of pharmaceutical products, specifically Maralixibat chloride, which is listed under Article 266a, paragraph 2 of the Law on Medicinal Products for Human Use. The total value of the contract is approximately €198,892.68. The buyer is the University Multi-Profile Hos

BGN 198,893UNIVERSITY MULTIPROFESSIONAL HOSPITAL FOR ACTIVE TREATMENT "SAINT GEORGE" EAD

Published 1 Jun 2025

AwardedHealthcare & MedicalBulgaria

Supply of Pharmaceutical Products

This contract involves the delivery of pharmaceutical products, specifically Ravulizumab, which are included in the list under Article 266a, paragraph 2 of the Law on Medicinal Products for Human Use. The buyer is the University Multi-Profile Hospital for Active Treatment 'St. George' EAD, and the a

BGN 102,996UNIVERSITY MULTIPROFESSIONAL HOSPITAL FOR ACTIVE TREATMENT "SAINT GEORGE" EAD

Published 11 May 2025

AwardedHealthcare & MedicalBulgaria

Pharmaceutical Products Supply

This contract involves the supply of pharmaceutical products, specifically Fluorescein, which is listed under Article 266a, paragraph 2 of the Law on Medicinal Products for Human Use. The buyer is the University Multi-Profile Hospital for Active Treatment 'St. George' EAD, and the total value of the

BGN 5,271UNIVERSITY MULTIPROFESSIONAL HOSPITAL FOR ACTIVE TREATMENT "SAINT GEORGE" EAD

Published 28 Apr 2025